China Digest: SmartX nets $29m; Hillhouse leads funding in Brosmed

Beijing, China. Source: Li Yang/Unsplash

SmartX has garnered 200 million yuan ($29 million) in its Series B+ and C rounds from Vertex Ventures China, Tianjin Venture Capital and HUA Capital while Brosmed Medical has secured ‘tens of millions of US dollars’ in its Series C funding led by Hillhouse Capital.

SmartX nets $29m in Series B+ and C rounds

SmartX Inc., a provider of computer and data infrastructure, has garnered 200 million yuan ($29 million) in its Series B+ and C rounds, per a company statement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter